Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases

Mediators of Inflammation

Volumn 2017, Issue , 2017, Pages

  Carniglia, Lila ^a   Ramírez, Delia ^a   Durand, Daniela ^a   Saba, Julieta ^a   Turati, Juan ^a   Caruso, Carla ^a   Scimonelli, Teresa N ^b   Lasaga, Mercedes ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE; CORTISTATIN; GHRELIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; LEPTIN; NEUROPEPTIDE; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; SOMATOSTATIN; TACHYKININ; VASOACTIVE INTESTINAL POLYPEPTIDE; AUTACOID;

CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; FLUID INTAKE; FOOD INTAKE; GLIA CELL; HUMAN; IMMUNOSURVEILLANCE; MICROGLIA; NERVE CONDUCTION; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NEUROPATHIC PAIN; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; REGULATORY MECHANISM; REPRODUCTION; REVIEW; STIMULUS RESPONSE; THERMOREGULATION; TISSUE INJURY; ANIMAL; GLIA; INFLAMMATION; MACROPHAGE ACTIVATION; METABOLISM; NEURALGIA;

ADRENOMEDULLIN; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; GHRELIN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEPTIN; MACROPHAGE ACTIVATION; MICROGLIA; NEURALGIA; NEURODEGENERATIVE DISEASES; NEUROGLIA; NEUROPEPTIDE Y; NEUROPEPTIDES; PAIN; PRO-OPIOMELANOCORTIN; TACHYKININS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 85010424297     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2017/5048616     Document Type: Review

References (269)

1. R. Franco, D. Fernndez-Surez, "Alternatively activated microglia, macrophages in the central nervous system, " Progress in Neurobiology, vol. 131, pp. 65-86, 2015.
2. H.-M. Gao, B. Liu, W. Zhang, J.-S. Hong, "Novel antiinflammatory therapy for Parkinson's disease, " Trends in Pharmacological Sciences, vol. 24, no. 8, pp. 395-401, 2003.
3. P. L. McGeer, E. G. McGeer, "The inflammatory response systemof brain: implications for therapy of Alzheimer, other neurodegenerative diseases, " Brain Research Reviews, vol. 21, no. 2, pp. 195-218, 1995.
4. A.Minagar, P. Shapshak, R. Fujimura, R.Ownby, M.Heyes, C. Eisdorfer, "The role of macrophage/microglia, astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, multiple sclerosis, " Journal of the Neurological Sciences, vol. 202, no. 1-2, pp. 13-23, 2002.
5. L. R. Frick, K. Williams, C. Pittenger, "Microglial dysregulation in psychiatric disease, " Clinical andDevelopmental Immunology, vol. 2013, Article ID 608654, 10 pages, 2013.
6. R.-R. Ji, T. Berta, M. Nedergaard, "Glia, pain: is chronic pain a gliopathy" Pain, vol. 154, pp. S10-S28, 2013.
7. R.-R. Ji, M. R. Suter, "p38 MAPK, microglial signaling, neuropathic pain, " Molecular Pain, vol. 3, article 33, 2007.
8. R.-R. Ji, T. Berta, M. Nedergaard, "Glia, pain: is chronic pain a gliopathy" Pain, vol. 154, supplement 1, pp. S10-S28, 2013.
9. J. A. M. Coull, S. Beggs, D. Boudreau , et al., "BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain, " Nature, vol. 438, no. 7070, pp. 1017-1021, 2005.
10. A. Ledeboer, E. M. Sloane, E. D. Milligan , et al., "Minocycline attenuates mechanical allodynia, proinflammatory cytokine expression in rat models of pain facilitation, " Pain, vol. 115, no. 1-2, pp. 71-83, 2005.
11. B. C. Hains, S. G.Waxman, "Activated microglia contribute to themaintenance of chronic pain after spinal cord injury, " The Journal of Neuroscience, vol. 26, no. 16, pp. 4308-4317, 2006.
12. Y.-W. Chang, S. G.Waxman, "Minocycline attenuatesmechanical allodynia, central sensitization following peripheral second-degree burn injury, " Journal of Pain, vol. 11, no. 11, pp. 1146-1154, 2010.
13. S. Pu, Y. Xu, D. Du , et al., "Minocycline attenuates mechanical allodynia, expression of spinal NMDA receptor 1 subunit in rat neuropathic pain model, " Journal of Physiology, Biochemistry, vol. 69, no. 3, pp. 349-357, 2013.
14. X.-Y.Hua, C. I. Svensson, T.Matsui, B. Fitzsimmons, T.L.Yaksh, M. Webb, "Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38MAPK in spinal microglia, " European Journal of Neuroscience, vol. 22, no. 10, pp. 2431-2440, 2005.
15. J. Mika, M. Osikowicz, W. Makuch, B. Przewlocka, "Minocycline, pentoxifylline attenuate allodynia, hyperalgesia, potentiate the effects of morphine in rat andmouse models of neuropathic pain, " European Journal of Pharmacology, vol. 560, no. 2-3, pp. 142-149, 2007.
16. J. Bakos, M. Zatkova, Z. Bacova, D. Ostatnikova, "The role of hypothalamic neuropeptides in neurogenesis, neuritogenesis, " Neural Plasticity, vol. 2016, Article ID 3276383, 10 pages, 2016.
17. J. M. Pocock, H. Kettenmann, "Neurotransmitter receptors on microglia, " Trends in Neurosciences, vol. 30, no. 10, pp. 527-535, 2007.
18. M. Pannell, F. Szulzewsky, V. Matyash, S. A. Wolf, H. Kettenmann, "The subpopulation of microglia sensitive to neurotransmitters/neurohormones is modulated by stimulation with LPS, interferon-, IL-4, " Glia, vol. 62, no. 5, pp. 667-679, 2014.
19. A. N. Eberle, The Melanotropins: Chemistry, Physiology, Mechanisms of Action, Karger, 1988.
20. J. E. S.Wikberg, R.Muceniece, I.Mandrika , et al., "New aspects on the melanocortins, their receptors, " Pharmacological Research, vol. 42, no. 5, pp. 393-420, 2000.
21. V. Caruso, M. C. Lagerstrm, P. K. Olszewski, R. Fredriksson, H. B. Schith, "Synaptic changes induced by melanocortin signalling, " Nature Reviews Neuroscience, vol. 15, no. 2, pp. 98-110, 2014.
22. A. Catania, S. Gatti, G. Colombo, J. M. Lipton, "Targeting melanocortin receptors as a novel strategy to control inflammation, " Pharmacological Reviews, vol. 56, no. 1, pp. 1-29, 2004.
23. H. B. Patel, T.Montero-Melendez, K. V. Greco, M. Perretti, "Melanocortin receptors as novel effectors of macrophage responses in inflammation, " Frontiers in Immunology, vol. 2, article 41, 2011.
24. N. Rajora, G. Boccoli, D. Burns, S. Sharma, A. P. Catania, J. M. Lipton, "Alpha-MSH modulates local, circulating tumor necrosis factor-alpha in experimental brain inflammation, " The Journal of Neuroscience, vol. 17, no. 6, pp. 2181-2186, 1997.
25. R. Delgado, A. Carlin, L. Airaghi , et al., "Melanocortin peptides inhibit production of proinflammatory cytokines, nitric oxide by activated microglia, " Journal of Leukocyte Biology, vol. 63, no. 6, pp. 740-745, 1998.
26. R. A. Star, N. Rajora, J. Huang, R. C. Stock, A. Catania, J. M. Lipton, "Evidence of autocrine modulation of macrophage nitric oxide synthase by-melanocyte-stimulating hormone, " Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 17, pp. 8016-8020, 1995.
27. N. Rajora, G. Ceriani, A. Catania, R. A. Star, M. T.Murphy, J. M. Lipton, " MSH production, receptors, influence on neopterin in a human monocyte/macrophage cell line, " Journal of Leukocyte Biology, vol. 59, no. 2, pp. 248-253, 1996.
28. D. Galimberti, P. Baron, L. Meda , et al., "-MSH peptides inhibit production of nitric oxide, tumor necrosis factor-by microglial cells activated with-amyloid, interferon , " Biochemical, Biophysical Research Communications, vol. 263, no. 1, pp. 251-256, 1999.
29. D. Giuliani, S. Leone, C. Mioni , et al., "Broad therapeutic treatment window of [Nle4, D-Phe7]-melanocyte-stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils, " European Journal of Pharmacology, vol. 538, no. 1-3, pp. 48-56, 2006.
30. D.Giuliani, A. Ottani, C.Mioni , et al., "Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins, " European Journal of Pharmacology, vol. 570, no. 1-3, pp. 57-65, 2007.
31. A. Forslin Aronsson, S. Spulber, L. M. Popescu , et al., "Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia, " Neuropeptides, vol. 40, no. 1, pp. 65-75, 2006.
32. E.-V. Schaible, A. Steinstrr, A. Jahn-Eimermacher , et al., "Single Administration of Tripeptide-MSH(11-13) Attenuates Brain Damage by Reduced Inflammation, Apoptosis after Experimental Traumatic Brain Injury in Mice, " PLoS ONE, vol. 8, no. 8, Article IDe71056, 2013.
33. M. Lasaga, L. Debeljuk, D. Durand, T. N. Scimonelli, C. Caruso, "Role of-melanocyte stimulating hormone, melanocortin 4 receptor in brain inflammation, " Peptides, vol. 29, no. 10, pp. 1825-1835, 2008.
34. C. Caruso, L. Carniglia, D. Durand, T. N. Scimonelli, M. Lasaga, "Melanocortins: anti-inflammatory, neuroprotective peptides, " inMental, BehaviouralDisorders andDiseases of the Nervous System, L. M. Martins, S. H. Y. Loh, Eds., INTECH, Rijeka, Croatia, 2012.
35. L. Roselli-Rehfuss, K. G.Mountjoy, L. S. Robbins , et al., "Identification of a receptor for melanotropin, other proopiomelanocortin peptides in the hypothalamus, limbic system, " Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 19, pp. 8856-8860, 1993.
36. K.G.Mountjoy, M. T. Mortrud, M. J. Low, R. B. Simerly, R. D. Cone, "Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine, autonomic control circuits in the brain, " Molecular Endocrinology, vol. 8, no. 10, pp. 1298-1308, 1994.
37. R. Bhardwaj, E. Becher, K.Mahnke , et al., "Evidence for the differential expression of the functional-melanocyte-stimulating hormone receptor MC-1 on human monocytes, " Journal of Immunology, vol. 158, no. 7, pp. 3378-3384, 1997.
38. U. Raap, T. Brzoska, S. Sohl , et al., "-melanocyte-stimulating hormone inhibits allergic airway inflammation, " Journal of Immunology, vol. 171, no. 1, pp. 353-359, 2003.
39. S. J. Getting, L. Gibbs, A. J. L. Clark, R. J. Flower, M. Perretti, "POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, inhibit neutrophil migration in acute experimental inflammation, " The Journal of Immunology, vol. 162, no. 12, pp. 7446-7453, 1999.
40. S. J. Getting, H. C. Christian, R. J. Flower, M. Perretti, "Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis, " Arthritis, Rheumatism, vol. 46, no. 10, pp. 2765-2775, 2002.
41. C.W. Lam, M. Perretti, S. J.Getting, "Melanocortin receptor signaling in RAW264.7 macrophage cell line, " Peptides, vol. 27, no. 2, pp. 404-412, 2006.
42. S. Taherzadeh, S. Sharma, V. Chhajlani , et al., "-MSH, its receptors in regulation of tumor necrosis factor-production by human monocyte/macrophages, " American Journal of Physiology-Regulatory Integrative, Comparative Physiology, vol. 276, no. 5, part 2, pp. R1289-R1294, 1999.
43. G. N. Andersen, M. Hgglund, O. Nagaeva , et al., "Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3, 5, pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes, " Scandinavian Journal of Immunology, vol. 61, no. 3, pp. 279-284, 2005.
44. C.W. Lam, S. J. Getting, M. Perretti, "In vitro, in vivo induction of heme oxygenase 1 in mouse macrophages following melanocortin receptor activation, " The Journal of Immunology, vol. 174, no. 4, pp. 2297-2304, 2005.
45. C.Lindberg, E.Hjorth, C.Post, B.Winblad, M.Schultzberg, "Cytokine production by a human microglial cell line: effects of-amyloid,-melanocyte-stimulating hormone, " Neurotoxicity Research, vol. 8, no. 3-4, pp. 267-276, 2005.
46. D. M. Dinulescu, R. D. Cone, "Agouti, agouti-related protein: analogies, contrasts, " Journal of Biological Chemistry, vol. 275, no. 10, pp. 6695-6698, 2000.
47. L. Carniglia, D. Durand, C. Caruso, M. Lasaga, "Effect of NDP-MSH on PPAR-,-expression, antiinflammatory cytokine release in rat astrocytes, microglia, " PLoS ONE, vol. 8, no. 2, Article ID e57313, 2013.
48. A. W. Taylor, "The immunomodulating neuropeptide alphamelanocyte-stimulating hormone (-MSH) suppresses LPSstimulated TLR4 with IRAK-M in macrophages, " Journal of Neuroimmunology, vol. 162, no. 1-2, pp. 43-50, 2005.
49. L. Carniglia, D. Ramez, D. Durand , et al., " [Nle4, D-Phe7]-MSH inhibits toll-like receptor (TLR)2-, TLR4-induced microglial activation, promotes aM2-like phenotype, " PLOS ONE, vol. 11, no. 6, p. e0158564, 2016.
50. A. Sarkar, Y. Sreenivasan, S. K. Manna, "-Melanocytestimulating hormone inhibits lipopolysaccharide-induced biological responses by downregulating CD14 from macrophages, " FEBS Letters, vol. 553, no. 3, pp. 286-294, 2003.
51. S. K. Manna, B. B. Aggarwal, "-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-B activation induced by various inflammatory agents, " Journal of Immunology, vol. 161, no. 6, pp. 2873-2880, 1998.
52. I. Mandrika, R. Muceniece, J. E. S. Wikberg, "Effects of melanocortin peptides on lipopolysaccharide/interferongamma-induced NF-kappaB DNA binding, nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action, " Biochemical Pharmacology, vol. 61, no. 5, pp. 613-621, 2001.
53. A.W. Taylor, J.W. Streilein, S.W. Cousins, "Identification of-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor, " Current Eye Research, vol. 11, no. 12, pp. 1199-1206, 1992.
54. N. Kawanaka, A.W. Taylor, "Localized retinal neuropeptide regulation of macrophage, microglial cell functionality, " Journal of Neuroimmunology, vol. 232, no. 1-2, pp. 17-25, 2011.
55. C. C. Chao, S. Hu, K. B. Shark, W. S. Sheng, G. Gekker, P. K. Peterson, "Activation ofMu opioid receptors inhibits microglial cell chemotaxis, " Journal of Pharmacology, Experimental Therapeutics, vol. 281, no. 2, pp. 998-1004, 1997.
56. J. Mika, K. Popiolek-Barczyk, E. Rojewska, W. Makuch, K. Starowicz, B. Przewlocka, "Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain, " PLoS ONE, vol. 9, no. 8, Article ID e104420, 2014.
57. C. C. Chao, G. Gekker, S. Hu , et al., "kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression, " Proceedings of the National Academy of Sciences, vol. 93, no. 15, pp. 8051-8056, 1996.
58. R. Ferreira, S. Xapelli, T. Santos , et al., "Neuropeptideymodulation of interleukin-1 (IL-1)-induced nitric oxide production in microglia, " The Journal of Biological Chemistry, vol. 285, no. 53, pp. 41921-41934, 2010.
59. A. Santos-Carvalho, C.A.Aveleira, F. Elvas, A. F. Ambrsio, C. Cavadas, "Neuropeptide Y receptors Y1, Y2 are present in neurons, glial cells in rat retinal cells in culture, " Investigative Ophthalmology, Visual Science, vol. 54, no. 1, pp. 429-443, 2013.
60. W.-K. Kim, Y. Kan, D. Ganea, R. P. Hart, I. Gozes, G. M. Jonakait, "Vasoactive intestinal peptide, pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-production in injured spinal cord, in activated microglia via a cAMP-dependent pathway, " Journal of Neuroscience, vol. 20, no. 10, pp. 3622-3630, 2000.
61. M. Delgado, G. M. Jonakait, D. Ganea, "Vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia, " Glia, vol. 39, no. 2, pp. 148-161, 2002.
62. J. Feindt, A. Schmidt, R. Mentlein, "Receptors, effects of the inhibitory neuropeptide somatostatin in microglial cells, " Molecular Brain Research, vol. 60, no. 2, pp. 228-233, 1998.
63. S. Fleisher-Berkovich, T. Filipovich-Rimon, S. Ben-Shmuel, C. Hlsmann, M. P. Kummer, M. T. Heneka, "Distinct modulation of microglial amyloid phagocytosis, migration by neuropeptidesi, " Journal of Neuroinflammation, vol. 7, article 61, 2010.
64. J.-P. Lai, G.-X. Zhan, D. E. Campbell, S. D. Douglas, W.-Z. Ho, "Detection of substance P, its receptor in human fetal microglia, " Neuroscience, vol. 101, no. 4, pp. 1137-1144, 2000.
65. A. Rasley, K. L. Bost, J. K. Olson, S. D.Miller, I.Marriott, "Expression of functional NK-1 receptors in murine microglia, " Glia, vol. 37, no. 3, pp. 258-267, 2002.
66. J. Zhu, C. Qu, X. Lu, S. Zhang, "Activation of microglia by histamine, substance P, " Cellular Physiology, Biochemistry, vol. 34, no. 3, pp. 768-780, 2014.
67. J. Priller, C. A. Haas, M. Reddington, G. W. Kreutzberg, "Calcitonin gene-related peptide, ATP induce immediate early gene expression in cultured rat microglial cells, " Glia, vol. 15, no. 4, pp. 447-457, 1995.
68. M. Reddington, J. Priller, J. Treichel, C. Haas, G. W. Kreutzberg, "Astrocytes, microglia as potential targets for calcitonin gene related peptide in the central nervous system, " Canadian Journal of Physiology, Pharmacology, vol. 73, no. 7, pp. 1047-1049, 1995.
69. A. Consonni, S. Morara, F. Codazzi, F. Grohovaz, D. Zacchetti, "Inhibition of lipopolysaccharide-induced microglia activation by calcitonin gene related peptide, adrenomedullin, " Molecular, Cellular Neuroscience, vol. 48, no. 2, pp. 151-160, 2011.
70. E. Pinteaux, W. Inoue, L. Schmidt, F. Molina-Holgado, N. J. Rothwell, G. N. Luheshi, "Leptin induces interleukin-1 release fromrat microglial cells through a caspase 1 independent mechanism, " Journal of Neurochemistry, vol. 102, no. 3, pp. 826-833, 2007.
71. C.-H. Tang, D.-Y. Lu, R.-S. Yang , et al., "Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, phosphatidylinositol 3-kinase, Akt, NF-B, p300 pathway in microglia, " Journal of Immunology, vol. 179, no. 2, pp. 1292-1302, 2007.
72. M. E. Bamberger, M. E. Harris, D. R. McDonald, J. Husemann, G. E. Landreth, "A cell surface receptor complex for fibrillar-amyloid mediates microglial activation, " The Journal of Neuroscience, vol. 23, no. 7, pp. 2665-2674, 2003.
73. I. S. Coraci, J. Husemann, J. W. Berman , et al., "CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains, can mediate production of reactive oxygen species in response to-amyloid fibrils, " The American Journal of Pathology, vol. 160, no. 1, pp. 101-112, 2002.
74. J. B. El Khoury, K. J. Moore, T. K. Means , et al., "CD36 mediates the innate host response to-amyloid, " The Journal of Experimental Medicine, vol. 197, no. 12, pp. 1657-1666, 2003.
75. A. Sierra, O.Abiega, A. Shahraz, H.Neumann, "Janus-faced microglia: beneficial, detrimental consequences of microglial phagocytosis, " Frontiers in Cellular Neuroscience, 2013.
76. A. Chan, T. Magnus, R. Gold, "Phagocytosis of apoptotic inflammatory cells by microglia, modulation by different cytokines: mechanism for removal of apoptotic cells in the inflamed nervous system, " GLIA, vol. 33, no. 1, pp. 87-95, 2001.
77. B. A. Durafourt, C. S.Moore, D. A. Zammit , et al., "Comparison of polarization properties of human adult microglia, bloodderived macrophages, " Glia, vol. 60, no. 5, pp. 717-727, 2012.
78. T. Montero-Melendez, H. B. Patel, M. Seed, S. Nielsen, T. E. N. Jonassen, M. Perretti, "The melanocortin agonist AP214 exerts anti-inflammatory, proresolving properties, " American Journal of Pathology, vol. 179, no. 1, pp. 259-269, 2011.
79. A. W. Taylor, "Alpha-melanocyte stimulating hormone (-MSH) is a post-caspase suppressor of apoptosis in RAW 264.7 macrophages, " PLoS ONE, vol. 8, no. 8, Article ID e74488, 2013.
80. T. A. Phan, A. W. Taylor, "The neuropeptides-MSH, NPY modulate phagocytosis, phagolysosome activation in RAW264.7 cells, " Journal of Neuroimmunology, vol. 260, no. 1-2, pp. 9-16, 2013.
81. K. Starowicz, B. Przewocka, "Therole of melanocortins, their receptors in inflammatory processes, nerve regeneration, nociception, " Life Sciences, vol. 73, no. 7, pp. 823-847, 2003.
82. K. Tsou, H. Khachaturian, H.Akil, S. J.Watson, "Immunocytochemical localization of pro-opiomelanocortin-derived peptides in the adult rat spinal cord, " Brain Research, vol. 378, no. 1, pp. 28-35, 1986.
83. K. Starowicz, W. Bilecki, A. Sieja, B. Przewlocka, R. Przewlocki, "Melanocortin 4 receptor is expressed in the dorsal root ganglions, down-regulated in neuropathic rats, " Neuroscience Letters, vol. 358, no. 2, pp. 79-82, 2004.
84. M. van der Kraan, J. B. Tatro, M. L. Entwistle , et al., "Expression of melanocortin receptors, pro-opiomelanocortin in the rat spinal cord in relation to neurotrophic effects of melanocortins, " Molecular Brain Research, vol. 63, no. 2, pp. 276-286, 1999.
85. M. Beltramo, M. Campanella, G. Tarozzo , et al., "Gene expression profiling of melanocortin system in neuropathic rats supports a role in nociception, " Molecular Brain Research, vol. 118, no. 1-2, pp. 111-118, 2003.
86. R. Bertorelli, S. Fredduzzi, G. Tarozzo , et al., "Endogenous, exogenous melanocortin antagonists induce anti-allodynic effects in a model of rat neuropathic pain, " Behavioural Brain Research, vol. 157, no. 1, pp. 55-62, 2005.
87. D. H. Vrinten, W. H. Gispen, G. J. Groen, R. A. H. Adan, "Antagonism of the melanocortin system reduces cold, mechanical allodynia in mononeuropathic rats, " Journal of Neuroscience, vol. 20, no. 21, pp. 8131-8137, 2000.
88. K. Starowicz, S. A. Mousa, I. Obara , et al., "Peripheral antinociceptive effects of MC4 receptor antagonists in a rat model of neuropathic pain-A Biochemical, Behavioral Study, " Pharmacological Reports, vol. 61, no. 6, pp. 1086-1095, 2009.
89. A. S. Kalange, D. M. Kokare, P. S. Singru, M. A. Upadhya, C. T. Chopde, N. K. Subhedar, "Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance, withdrawal hyperalgesia, " Brain Research, vol. 1181, no. 1, pp. 10-20, 2007.
90. K. Inoue, M. Tsuda, "Microglia, neuropathic pain, " GLIA, vol. 57, no. 14, pp. 1469-1479, 2009.
91. P. Sacerdote, S. Denis Donini, P. Paglia, F. Granucci, A. E. Panerai, P. Ricciardicastagnoli, "Cloned microglial cells but not macrophages synthesize beta-endorphin in response to CRH activation, " Glia, vol. 9, no. 4, pp. 305-310, 1993.
92. N. Gong, Q. Xiao, B. Zhu , et al., "Activation of spinal glucagonlike peptide-1 receptors specifically suppresses pain hypersensitivity, " TheJournal ofNeuroscience, vol. 34, no. 15, pp. 5322-5334, 2014.
93. H. Fan, T.-F. Li, N.Gong, Y.-X.Wang, "Shanzhiside methylester, the principle effective iridoid glycoside fromthe analgesic herb Lamiophlomis rotata, reduces neuropathic pain by stimulating spinal microglial-endorphin expression, " Neuropharmacology, vol. 101, pp. 98-109, 2016.
94. H. Fan, N. Gong, T.-F. Li , et al., "The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating-endorphin release from spinal microglia, " British Journal of Pharmacology, vol. 172, no. 1, pp. 64-79, 2015.
95. K. S. Sundar, L. S. Kamaraju, J. Dingfelder , et al., "Beta-endorphin enhances the replication of neurotropic human immunodeficiency virus in fetal perivascular microglia, " Journal of Neuroimmunology, vol. 61, no. 1, pp. 97-104, 1995.
96. X. Zeng, M. Y. Lin, D.Wang, Y. Zhang, Y.Hong, "Involvement of adrenomedullin in spinal glial activation following chronic administration of morphine in rats, " European Journal of Pain (United Kingdom), vol. 18, no. 9, pp. 1323-1332, 2014.
97. V. Raghavendra, M. D. Rutkowski, J. A. Deleo, "The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic, sham-operated rats, " Journal of Neuroscience, vol. 22, no. 22, pp. 9980-9989, 2002.
98. Y. Cui, Y. Chen, J.-L. Zhi, R.-X. Guo, J.-Q. Feng, P.-X. Chen, "Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance, " Brain Research, vol. 1069, no. 1, pp. 235-243, 2006.
99. Y. Cui, X.-X. Liao, W. Liu , et al., "A novel role of minocycline: attenuatingmorphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia, " Brain, Behavior, Immunity, vol. 22, no. 1, pp. 114-123, 2008.
100. A. Thorsell, M. Heilig, "Diverse functions of neuropeptide Y revealed using genetically modified animals, " Neuropeptides, vol. 36, no. 2-3, pp. 182-193, 2002.
101. D. Larhammar, E. Salaneck, "Molecular evolution of NPY receptor subtypes, " Neuropeptides, vol. 38, no. 4, pp. 141-151, 2004.
102. A. Santos-Carvalho, A. R. lvaro, J. Martins, A. F. Ambrsio, C. Cavadas, "Emerging novel roles of neuropeptide Y in the retina: from neuromodulation to neuroprotection, " Progress in Neurobiology, vol. 112, pp. 70-79, 2014.
103. R. Ferreira, T. Santos, L. Cortes , et al., "Neuropeptide y inhibits interleukin-1 beta-induced microglia motility, " Journal of Neurochemistry, vol. 120, no. 1, pp. 93-105, 2012.
104. J. Gonclves, C. F. Ribeiro, J. O. Malva, A. P. Silva, "Protective role of neuropeptide Y Y2 receptors in cell death, microglial response following methamphetamine injury, " European Journal of Neuroscience, vol. 36, no. 9, pp. 3173-3183, 2012.
105. A. Vezzani, S. Balosso, T. Ravizza, "The role of cytokines in the pathophysiology of epilepsy, " Brain, Behavior, Immunity, vol. 22, no. 6, pp. 797-803, 2008.
106. Q. J. Li, C. Z. Dong, W. L. Li, W. Bu, J. Wu, W. Q. Zhao, "Neuropeptide Y protects cerebral cortical neurons by regulating microglialimmune function, "Neural Regeneration Research, vol. 9, no. 9, pp. 959-967, 2014.
107. A. R.lvaro, J. Rosmaninho-Salgado, A. R. Santiago , et al., "NPY in rat retina is present in neurons, in endothelial cells, also in microglial, Mller cells, " Neurochemistry International, vol. 50, no. 5, pp. 757-763, 2007.
108. S. Bedoui, S. von Hrsten, T. Gebhardt, "A role for neuropeptide Y (NPY) in phagocytosis: implications for innate, adaptive immunity, " Peptides, vol. 28, no. 2, pp. 373-376, 2007.
109. R. Ferreira, T. Santos, M. Viegas , et al., "Neuropeptide Y inhibits interleukin-1-induced phagocytosis by microglial cells, " Journal of Neuroinflammation, vol. 8, article 169, 2011.
110. A. B. Intondi, M. N. Dahlgren, M. A. Eilers, B. K. Taylor, "Intrathecal neuropeptide Y reduces behavioral, molecular markers of inflammatory or neuropathic pain, " Pain, vol. 137, no. 2, pp. 352-365, 2008.
111. P. A. Smith, T. D. Moran, F. Abdulla, K. K. Tumber, B. K. Taylor, "Spinalmechanisms of NPY analgesia, " Peptides, vol. 28, no. 2, pp. 464-474, 2007.
112. S. I. Said, V. Mutt, "Polypeptide with broad biological activity: isolation from small intestine, " Science, vol. 169, no. 3951, pp. 1217-1218, 1970.
113. D. Ganea, K. M. Hooper, W. Kong, "The neuropeptide vasoactive intestinal peptide: direct effects on immune cells, involvement in inflammatory, autoimmune diseases, " Acta Physiologica, vol. 213, no. 2, pp. 442-452, 2015.
114. S. I. Said, "Vasoactive intestinal peptide, " Journal of Endocrinological Investigation, vol. 9, no. 2, pp. 191-200, 1986.
115. N. Itoh, K. Obata, N. Yanaihara, H. Okamoto, "Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27, " Nature, vol. 304, no. 5926, pp. 547-549, 1983.
116. A.Miyata, A. Arimura, R. R. Dahl , et al., "Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells, " Biochemical, Biophysical Research Communications, vol. 164, no. 1, pp. 567-574, 1989.
117. D. Vaudry, A. Falluel-Morel, S. Bourgault , et al., "Pituitary adenylate cyclase-activating polypeptide, its receptors: 20 years after the discovery, " Pharmacological Reviews, vol. 61, no. 3, pp. 283-357, 2009.
118. A. J. Harmar, J. Fahrenkrug, I. Gozes , et al., "Pharmacology, functions of receptors for vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1, " British Journal of Pharmacology, vol. 166, no. 1, pp. 4-17, 2012.
119. L. Dickson, K. Finlayson, "VPAC, PAC receptors: from ligands to function, " Pharmacology, Therapeutics, vol. 121, no. 3, pp. 294-316, 2009.
120. J. A. Waschek, "VIP, PACAP: neuropeptide modulators of CNS inflammation, injury, repair, " British Journal of Pharmacology, vol. 169, no. 3, pp. 512-523, 2013.
121. A. Dejda, P. Sokoowska, J. Z. Nowak, "Neuroprotective potential of three neuropeptides PACAP, VIP, PHI, " Pharmacological Reports, vol. 57, no. 3, pp. 307-320, 2005.
122. M. Delgado, J. Leceta, D. Ganea, "Vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia, " Journal of Leukocyte Biology, vol. 73, no. 1, pp. 155-164, 2003.
123. M. Delgado, "Vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide inhibit CBP-NF-B interaction in activated microglia, " Biochemical, Biophysical Research Communications, vol. 297, no. 5, pp. 1181-1185, 2002.
124. E.Gonzalez-Rey, M.Delgado, "Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activatedmacrophages, microglia, dendritic cells, " Brain, Behavior, Immunity, vol. 22, no. 1, pp. 35-41, 2008.
125. M. Delgado, "Vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia, " Biochemical, Biophysical Research Communications, vol. 293, no. 2, pp. 771-776, 2002.
126. H. Lee, K. Suk, "Selective modulation of microglial signal transduction by PACAP, " NeuroReport, vol. 15, no. 9, pp. 1469-1474, 2004.
127. K. Suk, J.-H. Park, W.-H. Lee, "Neuropeptide PACAP inhibits hypoxic activation of brain microglia: a protective mechanism against microglial neurotoxicity in ischemia, " Brain Research, vol. 1026, no. 1, pp. 151-156, 2004.
128. M. Delgado, "Inhibition of interferon (IFN)-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide. Inhibitory effect on CD40, IFN-induced protein-10, inducible nitric-oxide synthase expression, " The Journal of Biological Chemistry, vol. 278, no. 30, pp. 27620-27629, 2003.
129. W.-K. Kim, D. Ganea, G. M. Jonakait, "Inhibition of microglial CD40 expression by pituitary adenylate cyclaseactivating polypeptide is mediated by interleukin-10, " Journal of Neuroimmunology, vol. 126, no. 1-2, pp. 16-24, 2002.
130. M. Delgado, C.Martinez, D. Pozo , et al., "Vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-, IL-6, " Journal of Immunology, vol. 162, no. 2, pp. 1200-1205, 1999.
131. M. Delgado, E. J. Munoz-Elias, R. P. Gomariz, D. Ganea, "Vasoactive intestinal peptide, pituitary adenylate cyclaseactivating polypeptide enhance IL-10 production by murine macrophages: in vitro, in vivo studies, " Journal of Immunology, vol. 162, no. 3, pp. 1707-1716, 1999.
132. A. M. Bhandare, S. Mohammed, P. M. Pilowsky, M. M. J. Farnham, "Antagonism of PACAP or microglia function worsens the cardiovascular consequences of kainic-acid-induced seizures in rats, " Journal of Neuroscience, vol. 35, no. 5, pp. 2191-2199, 2015.
133. M. Delgado, "Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma, " The FASEB Journal, vol. 17, no. 13, pp. 1922-1924, 2003.
134. C. Brifault, M. Gras, D. Liot, V. May, D. Vaudry, O. Wurtz, "Delayed pituitary adenylate cyclase-activating polypeptide delivery after brain stroke improves functional recovery by inducing M2 microglia/macrophage polarization, " Stroke, vol. 46, no. 2, pp. 520-528, 2015.
135. X. Qin, Z.-Q. Sun, X.-J. Dai , et al., "Toll-like receptor 4 signaling is involved in PACAP-induced neuroprotection in BV2 microglial cells under OGD/reoxygenation, " Neurological Research, vol. 34, no. 4, pp. 379-389, 2012.
136. Y. Wada, T. Nakamachi, K. Endo , et al., "PACAP attenuates NMDA-induced retinal damage in association withmodulation of the microglia/macrophage status into an acquired deactivation subtype, " Journal of Molecular Neuroscience, vol. 51, no. 2, pp. 493-502, 2013.
137. M. Delgado, N. Varela, E. Gonzalez-Rey, "Vasoactive intestinal peptide protects against-amyloid-induced neurodegeneration by inhibiting microglia activation atmultiple levels, " Glia, vol. 56, no. 10, pp. 1091-1103, 2008.
138. M. Song, J.-X. Xiong, Y.-Y. Wang, J. Tang, B. Zhang, Y. Bai, "VIP enhances phagocytosis of fibrillar beta-amyloid by microglia, attenuates amyloid deposition in the brain of APP/PS1 mice, " PLoS ONE, vol. 7, no. 2, Article IDe29790, 2012.
139. S. Yang, J. Yang, Z. Yang , et al., "Pituitary adenylate cyclaseactivating polypeptide (PACAP) 38, PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: Potent regulators of microglia-mediated oxidative stress, " Journal of Pharmacology, ExperimentalTherapeutics, vol. 319, no. 2, pp. 595-603, 2006.
140. P. Jenner, "Oxidative stress in Parkinson's disease, " Annals of Neurology, vol. 53, no. S3, pp. S26-S38, 2003.
141. M.Delgado andD.Ganea, "Neuroprotective effect of vasoactive intestinal peptide (VIP) in amousemodel of Parkinson's disease by blocking microglial activation, " The FASEB Journal, vol. 17, no. 8, pp. 944-946, 2003.
142. H. Kato, A. Ito, J. Kawanokuchi , et al., "Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells, " Multiple Sclerosis, vol. 10, no. 6, pp. 651-659, 2004.
143. T. Dickinson, S. M. Fleetwood-Walker, "VIP, PACAP: very important in pain" Trends in Pharmacological Sciences, vol. 20, no. 8, pp. 324-329, 1999.
144. E.M. Garry, A. Delaney, G. Blackburn-Munro , et al., "Activation of p38, p42/44 MAP kinase in neuropathic pain: involvement of VPAC2, NK2 receptors, mediation by spinal glia, " Molecular, Cellular Neuroscience, vol. 30, no. 4, pp. 523-537, 2005.
145. M.Grimaldi, S. Cavallaro, "Functional, molecular diversity of PACAP/VIP receptors in cortical neurons, type I astrocytes, " European Journal of Neuroscience, vol. 11, no. 8, pp. 2767-2772, 1999.
146. M. Delgado, E. J. Munoz-Elias, R. P. Gomariz, D. Ganea, "VIP, PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFN synthesis by T cells, " Journal of Neuroimmunology, vol. 96, no. 2, pp. 167-181, 1999.
147. M. Delgado, D. Ganea, "Vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-B-dependent gene activation at multiple levels in the human monocytic cell line THP-1, " The Journal of Biological Chemistry, vol. 276, no. 1, pp. 369-380, 2001.
148. M. Delgado, E. J. Munoz-Elias, Y. Kan , et al., "Vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor transcriptional activation by regulating nuclear factor-kB, cAMP response elementbinding protein/c-Jun, " Journal of Biological Chemistry, vol. 273, no. 47, pp. 31427-31436, 1998.
149. Y. C. Patel, "Somatostatin, its receptor family, " Frontiers in Neuroendocrinology, vol. 20, no. 3, pp. 157-198, 1999.
150. J. Grinshpun, L. Tveria, S. Fleisher-Berkovich, "Differential regulation of prostaglandin synthesis in neonatal rat microglia, astrocytes by somatostatin, " European Journal of Pharmacology, vol. 584, no. 2-3, pp. 312-317, 2008.
151. C. Dello Russo, L. Lisi, P. Navarra, G. Tringali, "Diverging effects of cortistatin, somatostatin on the production, release of prostanoids from rat cortical microglia, astrocytes, " Journal of Neuroimmunology, vol. 213, no. 1-2, pp. 78-83, 2009.
152. G. Tundo, C. Ciaccio, D. Sbardella , et al., "Somatostatin modulates insulin-degrading-enzyme metabolism: implications for the regulation of microglia activity inAD, " PLoS ONE, vol. 7, no. 4, Article ID e34376, 2012.
153. L. Bai, X. Zhang, X. Li , et al., "Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia, "MolecularMedicine Reports, vol. 12, no. 1, pp. 1002-1008, 2015.
154. S. V. More, H. Kumar, I. S. Kim, S.-Y. Song, D.-K. Choi, "Cellular, molecularmediators of neuroinflammation in the pathogenesis of Parkinson's disease, "Mediators of Inflammation, vol. 2013, Article ID 952375, 12 pages, 2013.
155. E. Pintr, Z. Helyes, J. Szolcsnyi, "Inhibitory effect of somatostatin on inflammation, nociception, " Pharmacology andTherapeutics, vol. 112, no. 2, pp. 440-456, 2006.
156. L. De Lecea, J. R. Criado, O. Prospero-Garcia , et al., "A cortical neuropeptide with neuronal depressant, sleep-modulating properties, " Nature, vol. 381, no. 6579, pp. 242-245, 1996.
157. L. de Lecea, "Cortistatin-functions in the central nervous system, " Molecular, Cellular Endocrinology, vol. 286, no. 1-2, pp. 88-95, 2008.
158. R. Deghenghi, M. Papotti, E. Ghigo, G. Muccioli, "Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland, " Journal of Endocrinological Investigation, vol. 24, no. 1, pp.RC1-RC3, 2001.
159. N. Robas, E. Mead, M. Fidock, "MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion, " Journal of Biological Chemistry, vol. 278, no. 45, pp. 44400-44404, 2003.
160. M. Kamohara, A. Matsuo, J. Takasaki , et al., "Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides, " Biochemical, Biophysical Research Communications, vol. 330, no. 4, pp. 1146-1152, 2005.
161. J. Crdoba-Chacn, M. D. Gahete, M. Duran-Prado , et al., "Identification, characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents, " Cellular, Molecular Life Sciences, vol. 67, no. 7, pp. 1147-1163, 2010.
162. J. Crdoba-Chacn, M. D. Gahete, M. Durn-Prado, R. M. Luque, J. P. Castano, "Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology, " Annals of the New York Academy of Sciences, vol. 1220, no. 1, pp. 6-15, 2011.
163. V. A. S. H. Dalm, P. M. Van Hagen, P. M. Van Koetsveld , et al., "Expression of somatostatin, cortistatin, somatostatin receptors in human monocytes, macrophages, dendritic cells, " American Journal of Physiology-Endocrinology, Metabolism, vol. 285, no. 2, pp. E344-E353, 2003.
164. V. A. Dalm, P.M.VanHagen, P.M. VanKoetsveld , et al., "Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system, " The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 1, pp. 270-276, 2003.
165. E. Gonzalez-Rey, N. Varela, A. F. Sheibanie, A. Chorny, D. Ganea, M. Delgado, "Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 11, pp. 4228-4233, 2006.
166. E. Gonzalez-Rey, A. Chorny, G. Robledo, M. Delgado, "Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia, " The Journal of Experimental Medicine, vol. 203, no. 3, pp. 563-571, 2006.
167. E. Gonzalez-Rey, A. Chorny, R. G. Del Moral, N. Varela, M. Delgado, "Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory, Th1 responses, " Annals of the Rheumatic Diseases, vol. 66, no. 5, pp. 582-588, 2007.
168. C.-T. Chiu, L.-L. Wen, H.-P. Pao, J.-Y. Wang, "Cortistatin is induced in brain tissue, exerts neuroprotection in a rat model of bacterial meningoencephalitis, " Journal of Infectious Diseases, vol. 204, no. 10, pp. 1563-1572, 2011.
169. L. Souza-Moreira, M. Morell, V. Delgado-Maroto , et al., "Paradoxical effect of cortistatin treatment, its deficiency on experimental autoimmune encephalomyelitis, " The Journal of Immunology, vol. 191, no. 5, pp. 2144-2154, 2013.
170. M. Morell, M. Camprub-Robles, M. D. Culler, L. de Lecea, M. Delgado, "Cortistatin attenuates inflammatory pain via spinal, peripheral actions, " Neurobiology of Disease, vol. 63, pp. 141-154, 2014.
171. M. Morell, L. Souza-Moreira, M. Caro , et al., "Analgesic effect of the neuropeptide cortistatin in murine models of arthritic inflammatory pain, " Arthritis & Rheumatism, vol. 65, no. 5, pp. 1390-1401, 2013.
172. A. Capuano, D. Currò, P. Navarra, G. Tringali, "Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin, " Peptides, vol. 32, no. 1, pp. 138-143, 2011.
173. M. S. Steinhoff, B. vonMentzer, P. Geppetti, C. Pothoulakis, N.W. Bunnett, "Tachykinins, their receptors: contributions to physiological control, the mechanisms of disease, " Physiological Reviews, vol. 94, no. 1, pp. 265-301, 2014.
174. Y. Zhang, L. Lu, C. Furlonger, G. E.Wu, C. J. Paige, "Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis, " Nature Immunology, vol. 1, no. 5, pp. 392-397, 2000.
175. M. M. Kurtz, R. Wang, M. K. Clements , et al., "Identification, localization, receptor characterization of novel mammalian substance P-like peptides, " Gene, vol. 296, no. 1-2, pp. 205-212, 2002.
176. M.A. Laurenzi, C. Arcuri, R. Rossi, P.Marconi, V. Bocchini, "Effects of microenvironment on morphology, function of the microglial cell line BV-2, " Neurochemical Research, vol. 26, no. 11, pp. 1209-1216, 2001.
177. D. Giulian, M. Corpuz, B. Richmond, E. Wendt, E. R.Hall, "Activated microglia are the principal glial source of thromboxane in the central nervous system, " Neurochemistry International, vol. 29, no. 1, pp. 65-76, 1996.
178. K.Maeda, M. Nakai, S.Maeda, T. Kawamata, T.Yamaguchi, C. Tanaka, "Possible different mechanism between amyloidbeta (25-35)-, substance P-induced chemotaxis of murine microglia, " Gerontology, vol. 43, supplement 1, pp. 11-15, 1997.
179. F. C.Martin, P. A. Anton, J. A. Gornbein, F. Shanahan, J. E. Merrill, "Production of interleukin-1 by microglia in response to substance P: role for a non-classical NK-1 receptor, " Journal of Neuroimmunology, vol. 42, no. 1, pp. 53-60, 1993.
180. L. P.McCluskey, L. A. Lampson, "Local immune regulation in the central nervous system by substance P vs. glutamate, " Journal of Neuroimmunology, vol. 116, no. 2, pp. 136-146, 2001.
181. A. Rasley, I. Marriott, C. R. Halberstadt, K. L. Bost, J. Anguita, "Substance P augments Borrelia burgdorferi-induced prostaglandin E2 production by murine microglia, " The Journal of Immunology, vol. 172, no. 9, pp. 5707-5713, 2004.
182. V. S. Chauhan, D. G. Sterka, D. L. Gray, K. L. Bost, I. Marriott, "Neurogenic exacerbation of microglial, astrocyte responses to Neisseria meningitidis, Borrelia burgdorferi, " The Journal of Immunology, vol. 180, no. 12, pp. 8241-8249, 2008.
183. E.Thornton, R. Vink, "Substance p, its tachykinin NK1 receptor: a novel neuroprotective target for parkinson's disease, " Neural Regeneration Research, vol. 10, no. 9, pp. 1403-1405, 2015.
184. M. J. Brownstein, E. A.Mroz, J. Stephen Kizer, M. Palkovits, S. E. Leeman, "Regional distribution of substance P in the brain of the rat, " Brain Research, vol. 116, no. 2, pp. 299-305, 1976.
185. M. L. Block, G. Li, L.Qin , et al., "Potent regulation ofmicrogliaderived oxidative stress, dopaminergic neuron survival: substance P vs. dynorphin, " The FASEB Journal, vol. 20, no. 2, pp. 251-258, 2006.
186. Q. Wang, C.-H. Chu, L. Qian , et al., "Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidase, " Journal of Neuroscience, vol. 34, no. 37, pp. 12490-12503, 2014.
187. S. Tumati, T. M. Largent-Milnes, A. I. Keresztes , et al., "Tachykinin NK1 receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia, astrocyte activation, " European Journal of Pharmacology, vol. 684, no. 1-3, pp. 64-70, 2012.
188. W.-W. Li, T.-Z. Guo, X. Shi , et al., "Substance P spinal signaling induces glial activation, nociceptive sensitization after fracture, " Neuroscience, vol. 310, pp. 73-90, 2015.
189. C. I. Svensson, M. Marsala, A. Westerlund , et al., "Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing, " Journal of Neurochemistry, vol. 86, no. 6, pp. 1534-1544, 2003.
190. L. Leung, C. M. Cahill, "TNF-, neuropathic pain-a review, " Journal of Neuroinflammation, vol. 7, articleno. 27, 2010.
191. N. Kiguchi, T. Maeda, Y. Kobayashi, S. Kishioka, "Upregulation of tumor necrosis factor-alpha in spinal cord contributes to vincristine-induced mechanical allodynia in mice, " Neuroscience Letters, vol. 445, no. 2, pp. 140-143, 2008.
192. Z. Zhou, X. Peng, J. Hagshenas, R. Insolera, D. J. Fink, M. Mata, "A novel cell-cell signaling by microglial transmembrane TNF with implications for neuropathic pain, " Pain, vol. 151, no. 2, pp. 296-306, 2010.
193. M. H. Jiang, E. Chung, G. F. Chi , et al., "Substance P inducesM2-type macrophages after spinal cord injury, " NeuroReport, vol. 23, no. 13, pp. 786-792, 2012.
194. E. C. Leal, E. Carvalho, A. Tellechea , et al., "Substance P promotes wound healing in diabetes by modulating inflammation, macrophage phenotype, " American Journal of Pathology, vol. 185, no. 6, pp. 1638-1648, 2015.
195. D. A.Nelson, I.Marriott, K. L. Bost, "Expressionof hemokinin 1 mRNA by murine dendritic cells, " Journal of Neuroimmunology, vol. 155, no. 1-2, pp. 94-102, 2004.
196. A. Sakai, K. Takasu, M. Sawada, H. Suzuki, "Hemokinin-1 gene expression is upregulated in microglia activated by lipopolysaccharide through NF-B, p38 MAPK signaling pathways, " PLoS ONE, vol. 7, no. 2, Article ID e32268, 2012.
197. T. Matsumura, A. Sakai, M. Nagano , et al., "Increase in hemokinin-1mRNA in the spinal cord during the early phase of a neuropathic pain state, " British Journal of Pharmacology, vol. 155, no. 5, pp. 767-774, 2008.
198. S. G. Amara, V. Jonas, M. G. Rosenfeld, E. S. Ong, R. M. Evans, "Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products, " Nature, vol. 298, no. 5871, pp. 240-244, 1982.
199. J. Roh, C. L. Chang, A. Bhalla, C. Klein, S. Y. T. Hsu, "Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes, " Journal of Biological Chemistry, vol. 279, no. 8, pp. 7264-7274, 2004.
200. K. Kitamura, K. Kangawa, M. Kawamoto , et al., "Adrenomedullin: a novel hypotensive peptide isolated fromhuman pheochromocytoma, " Biochemical, Biophysical Research Communications, vol. 192, no. 2, pp. 553-560, 1993.
201. P. Westermark, C. Wernstedt, E. Wilander, K. Sletten, "A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas, " Biochemical, Biophysical Research Communications, vol. 140, no. 3, pp. 827-831, 1986.
202. G. J. S. Cooper, A. C. Willis, A. Clark, R. C. Turner, R. B. Sim, K. B. M. Reid, "Purification, characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients, " Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 23, pp. 8628-8632, 1987.
203. S. D. Brain, A. D. Grant, "Vascular actions of calcitonin gene-related peptide, adrenomedullin, " Physiological Reviews, vol. 84, no. 3, pp. 903-934, 2004.
204. L.M.McLatchie, N. J. Fraser, M. J.Main, et al., "RAMPS regulate the transport, ligand specificity of the calcitonin-receptorlike receptor, " Nature, vol. 393, no. 6683, pp. 333-339, 1998.
205. L. Y. F. Wong, B.M. Y. Cheung, Y.-Y. Li, F. Tang, "Adrenomedullin is both proinflammatory, antiinflammatory: its effects on gene expression, secretion of cytokines, macrophage migration inhibitory factor in NR8383 macrophage cell line, " Endocrinology, vol. 146, no. 3, pp. 1321-1327, 2005.
206. J. Springer, P. Geppetti, A. Fischer, D. A. Groneberg, "Calcitonin gene-related peptide as inflammatory mediator, " Pulmonary Pharmacology & Therapeutics, vol. 16, no. 3, pp. 121-130, 2003.
207. J. Betowski, A. Jamroz, "Adrenomedullin-what do we know 10 years since its discovery" Polish Journal of Pharmacology, vol. 56, no. 1, pp. 5-27, 2004.
208. A. Ladoux, C. Frelin, "Coordinated up-regulation by hypoxia of adrenomedullin, one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier, " Journal of Biological Chemistry, vol. 275, no. 51, pp. 39914-39919, 2000.
209. E. Tixier, C. Leconte, O. Touzani, S. Roussel, E. Petit, M. Bernaudin, "Adrenomedullin protects neurons against oxygen glucose deprivation stress in an autocrine, paracrine manner, " Journal of Neurochemistry, vol. 106, no. 3, pp. 1388-1403, 2008.
210. M. Bernaudin, Y. Tang, M. Reilly, E. Petit, F. R. Sharp, "Brain genomic response following hypoxia, re-oxygenation in the neonatal rat: identification of genes that might contribute to hypoxia-induced ischemic tolerance, " Journal of Biological Chemistry, vol. 277, no. 42, pp. 39728-39738, 2002.
211. S. Oba, M. Hino, T. Fujita, "Adrenomedullin protects against oxidative stress-induced podocyte injury as an endogenous antioxidant, " Nephrology Dialysis Transplantation, vol. 23, no. 2, pp. 510-517, 2008.
212. T. Yoshimoto, N. Fukai, R. Sato , et al., "Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation invascular smoothmuscle cells, " Endocrinology, vol. 145, no. 7, pp. 3331-3337, 2004.
213. T. Yoshimoto, N. Gochou, N. Fukai, T. Sugiyama, M. Shichiri, Y.Hirata, "Adrenomedullin inhibits angiotensin II-induced oxidative stress, gene expression in rat endothelial cells, " Hypertension Research, vol. 28, no. 2, pp. 165-172, 2005.
214. E. N. Chini, C. C. S. Chini, C. Bolliger , et al., "Cytoprotective effects of adrenomedullin in glomerular cell injury: central role of cAMP signaling pathway, " Kidney International, vol. 52, no. 4, pp. 917-925, 1997.
215. N.Miyamoto, R.Tanaka, T. Shimosawa , et al., "ProteinkinaseAdependent suppression of reactive oxygen species in transient focal ischemia in adrenomedullin-deficient mice, " Journal of Cerebral Blood Flow&Metabolism, vol. 29, no. 11, pp. 1769-1779, 2009.
216. B. Engelhardt, R. M. Ransohoff, "The ins, outs of T-lymphocyte trafficking to the CNS: anatomical sites, molecular mechanisms, " Trends in Immunology, vol. 26, no. 9, pp. 485-495, 2005.
217. M. Pedreno, M. Morell, G. Robledo , et al., "Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels, " Brain, Behavior, Immunity, vol. 37, pp. 152-163, 2014.
218. C. Sardi, L. Zambusi, A. Finardi , et al., "Involvement of calcitonin gene-related peptide, receptor component protein in experimental autoimmune encephalomyelitis, " Journal of Neuroimmunology, vol. 271, no. 1-2, pp. 18-29, 2014.
219. R.-Q. Sun, Y.-J. Tu, N. B. Lawand, J.-Y. Yan, Q. Lin, W. D. Willis, "Calcitonin gene-related peptide receptor activation produces PKA-, PKC-dependent mechanical hyperalgesia, central sensitization, " Journal of Neurophysiology, vol. 92, no. 5, pp. 2859-2866, 2004.
220. R. J. Cady, J. R. Glenn, K. M. Smith, P. L. Durham, "Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons, glia implicated in peripheral, central sensitization, " Molecular Pain, vol. 7, article 94, 2011.
221. F. R. Nieto, A. K. Clark, J. Grist, V. Chapman, M.Malcangio, "Calcitonin gene-related peptide-expressing sensory neurons, spinal microglial reactivity contribute to pain states in collagen-induced arthritis, " Arthritis & Rheumatology, vol. 67, no. 6, pp. 1668-1677, 2015.
222. Z.Wang, W.Ma, J.-G. Chabot, R. Quirion, "Morphological evidence for the involvement of microglial p38 activation in CGRP-associated development of morphine antinociceptive tolerance, " Peptides, vol. 31, no. 12, pp. 2179-2184, 2010.
223. Z. Wang, W. Ma, J.-G. Chabot, R. Quirion, "Cell-type specific activation of p38, ERK mediates calcitonin generelated peptide involvement in tolerance to morphine-induced analgesia, " FASEB Journal, vol. 23, no. 8, pp. 2576-2586, 2009.
224. Z. Wang, W. Ma, J.-G. Chabot, R. Quirion, "Calcitonin gene-related peptide as a regulator of neuronal CaMKII-CREB, microglial p38-NFB, astroglial ERK-Stat1/3 cascadesmediating the development of tolerance to morphine-induced analgesia, " Pain, vol. 151, no. 1, pp. 194-205, 2010.
225. H. Mnzberg, C. D. Morrison, "Structure, production, signaling of leptin, "Metabolism: Clinical, Experimental, vol. 64, no. 1, pp. 13-23, 2015.
226. R. C. Frederich, A. Hamann, S. Anderson, B. Lollmann, B. B. Lowell, J. S. Flier, "Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action, " Nature Medicine, vol. 1, no. 12, pp. 1311-1314, 1995.
227. M. W. Schwartz, E. Peskind, M. Raskind, E. J. Boyko, D. Porte Jr., "Cerebrospinal fluid leptin levels: relationship to plasma levels, to adiposity inhumans, " Nature Medicine, vol. 2, no. 5, pp. 589-593, 1996.
228. W. A. Banks, A. J. Kastin, W. Huang, J. B. Jaspan, L. M. Maness, "Leptin enters the brain by a saturable system independent of insulin, " Peptides, vol. 17, no. 2, pp. 305-311, 1996.
229. B. Morash, A. Li, P. R. Murphy, M. Wilkinson, E. Ur, "Leptin gene expression in the brain, pituitary gland, " Endocrinology, vol. 140, no. 12, pp. 5995-5998, 1999.
230. P. Hekerman, J. Zeidler, S. Bamberg-Lemper , et al., "Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines, " The FEBS Journal, vol. 272, no. 1, pp. 109-119, 2005.
231. C. F. Elias, J. F. Kelly, C. E. Lee , et al., "Chemical characterization of leptin-activated neurons in the rat brain, " Journal of Comparative Neurology, vol. 423, no. 2, pp. 261-281, 2000.
232. M. M. Scott, J. L. Lachey, S. M. Sternson , et al., "Leptin targets in themouse brain, " Journal of Comparative Neurology, vol. 514, no. 5, pp. 518-532, 2009.
233. M.W. Schwartz, R. J. Seeley, S. C.Woods , et al., "Leptinincreases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus, " Diabetes, vol. 46, no. 12, pp. 2119-2123, 1997.
234. M.W. Schwartz, D. G. Baskin, T. R. Bukowski , et al., "Specificity of leptin action on elevated blood glucose levels, hypothalamic neuropeptide Y gene expression in ob/ob mice, " Diabetes, vol. 45, no. 4, pp. 531-535, 1996.
235. T. M. Mizuno, C. V. Mobbs, "Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin, stimulated by fasting, " Endocrinology, vol. 140, no. 2, pp. 814-817, 1999.
236. S. G. Bouret, "Neurodevelopmental actions of leptin, " Brain Research, vol. 1350, pp. 2-9, 2010.
237. A. La Cava, G.Matarese, "Theweight of leptin in immunity, " Nature Reviews Immunology, vol. 4, no. 5, pp. 371-379, 2004.
238. P. Sarraf, R. C. Frederich, E. M. Turner , et al., "Multiple cytokines, acute inflammation raisemouse leptin levels: potential role in inflammatory anorexia, " Journal of Experimental Medicine, vol. 185, no. 1, pp. 171-175, 1997.
239. C. Grunfeld, C. Zhao, J. Fuller , et al., "Endotoxin, cytokines induce expression of leptin, the ob gene product, in hamsters: A role for leptin in the anorexia of infection, " Journal of Clinical Investigation, vol. 97, no. 9, pp. 2152-2157, 1996.
240. C. Sachot, S. Poole, G. N. Luheshi, "Circulating leptinmediates lipopolysaccharide-induced anorexia, fever in rats, " Journal of Physiology, vol. 561, no. 1, pp. 263-272, 2004.
241. L. M. Harden, I. du Plessis, S. Poole, H. P. Laburn, "Interleukin-6, leptin mediate lipopolysaccharide-induced fever, sickness behavior, " Physiology, Behavior, vol. 89, no. 2, pp. 146-155, 2006.
242. T. Hosoi, Y. Okuma, Y. Nomura, "Expression of leptin receptors, induction of IL-1 transcript in glial cells, " Biochemical, Biophysical Research Communications, vol. 273, no. 1, pp. 312-315, 2000.
243. Y. Gao, N. Ottaway, S. C. Schriever , et al., "Hormones, diet, but not body weight, control hypothalamic microglial activity, " GLIA, vol. 62, no. 1, pp. 17-25, 2014.
244. V. Lafrance, W. Inoue, B.Kan, G. N. Luheshi, "Leptinmodulates cellmorphology, cytokine release in microglia, " Brain, Behavior, Immunity, vol. 24, no. 3, pp. 358-365, 2010.
245. A. J. Kiliaan, I. A. C. Arnoldussen, D.R.Gustafson, "Adipokines: a link between obesity, dementia" The Lancet Neurology, vol. 13, no. 9, pp. 913-923, 2014.
246. D. J. Bonda, J. G. Stone, S. L. Torres , et al., "Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance, " Journal of Neurochemistry, vol. 128, no. 1, pp. 162-172, 2014.
247. C. Davis, J. Mudd, M. Hawkins, "Neuroprotective effects of leptin in the context of obesity, metabolic disorders, " Neurobiology of Disease, vol. 72, pp. 61-71, 2014.
248. G. Lim, S.Wang, Y. Zhang, Y. Tian, J. Mao, "Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents, " Journal of Clinical Investigation, vol. 119, no. 2, pp. 295-304, 2009.
249. T. Maeda, N. Kiguchi, Y. Kobayashi, T. Ikuta, M. Ozaki, S. Kishioka, "Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 31, pp. 13076-13081, 2009.
250. C. M. Fernndez-Martos, P. Gonzlez, F. J. Rodriguez, "Acute leptin treatment enhances functional recovery after spinal cord injury, " PLoS ONE, vol. 7, no. 4, Article ID e35594, 2012.
251. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, K. Kangawa, "Ghrelin is a growth-hormone-releasing acylated peptide fromstomach, " Nature, vol. 402, no. 6762, pp. 656-660, 1999.
252. K. Toshinai, M. S. Mondal, M. Nakazato , et al., "Upregulation of ghrelin expression in the stomach upon fasting, insulininduced hypoglycemia, leptin administration, " Biochemical, Biophysical Research Communications, vol. 281, no. 5, pp. 1220-1225, 2001.
253. M. Shintani, Y. Ogawa, K. Ebihara , et al., "Rapid publication ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway, " Diabetes, vol. 50, no. 2, pp. 227-232, 2001.
254. B. Callaghan, J. B. Furness, "Novel, conventional receptors for ghrelin, desacyl-ghrelin, pharmacologically related compounds, " Pharmacological Reviews, vol. 66, no. 4, pp. 984-1001, 2014.
255. H. Hosoda, M. Kojima, H. Matsuo, K. Kangawa, "Ghrelin, des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue, " Biochemical, Biophysical Research Communications, vol. 279, no. 3, pp. 909-913, 2000.
256. X.-M. Guan, H. Yu, O. C. Palyha , et al., "Distribution of mRNA encoding the growth hormone secretagogue receptor in brain, peripheral tissues, " Molecular Brain Research, vol. 48, no. 1, pp. 23-29, 1997.
257. M. Nakazato, N. Murakami, Y. Date , et al., "A role for ghrelin in the central regulation of feeding, " Nature, vol. 409, no. 6817, pp. 194-198, 2001.
258. T. Y. Yune, J. Y. Lee, G. Y. Jung , et al., "Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury, " The Journal of Neuroscience, vol. 27, no. 29, pp. 7751-7761, 2007.
259. J. Y. Lee, H. Chung, Y. S. Yoo , et al., "Inhibition of apoptotic cell death by ghrelin improves functional recovery after spinal cord injury, " Endocrinology, vol. 151, no. 8, pp. 3815-3826, 2010.
260. J. Y. Lee, T. Y. Yune, "Ghrelin inhibits oligodendrocyte cell death by attenuating microglial activation, " Endocrinology, Metabolism, vol. 29, no. 3, pp. 371-378, 2014.
261. J. Y. Lee, H. Y. Choi, T. Y. Yune, "MMP-3 secreted from endothelial cells of blood vessels after spinal cord injury activates microglia, leading to oligodendrocyte cell death, " Neurobiology of Disease, vol. 82, pp. 141-151, 2015.
262. J. Lee, E. Lim, Y. Kim, E. Li, S. Park, "Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus, " Journal of Endocrinology, vol. 205, no. 3, pp. 263-270, 2010.
263. S. Lee, Y. Kim, E. Li, S. Park, "Ghrelin protects spinal cord motoneurons against chronic glutamate excitotoxicity by inhibiting microglial activation, " The Korean Journal of Physiology & Pharmacology, vol. 16, no. 1, pp. 43-48, 2012.
264. M. Moon, H. G. Kim, L. Hwang , et al., "Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of parkinson's disease by blocking microglial activation, " Neurotoxicity Research, vol. 15, no. 4, pp. 332-347, 2009.
265. M.-M. Theil, S. Miyake, M. Mizuno , et al., "Suppression of experimental autoimmune encephalomyelitis by Ghrelin, " The Journal of Immunology, vol. 183, no. 4, pp. 2859-2866, 2009.
266. M. D. Gahete, J.Crdoba-Chacn, R.D. Kineman, R.M. Luque, J. P. Castano, "Role of ghrelin system in neuroprotection, cognitive functions: implications in Alzheimer's disease, " Peptides, vol. 32, no. 11, pp. 2225-2228, 2011.
267. A. Demers, N. McNicoll, M. Febbraio , et al., "Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study, " Biochemical Journal, vol. 382, no. 2, pp. 417-424, 2004.
268. I. Bulgarelli, L. Tamiazzo, E. Bresciani , et al., "Desacyl-ghrelin, synthetic GH-secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by-amyloid fibrils, " Journal of Neuroscience Research, vol. 87, no. 12, pp. 2718-2727, 2009.
269. C.-H. Zhou, X. Li, Y.-Z. Zhu , et al., "Ghrelin alleviates neuropathic pain through GHSR-1a-mediated suppression of the p38MAPK/NF-B pathway in a rat chronic constriction injury model, " Regional Anesthesia, Pain Medicine, vol. 39, no. 2, pp. 137-148, 2014.